NVO
Novo Nordisk A/S
NVO's fundamentals are mixed: it turned 15% of its revenue into free cash flow, but its operating margin fell 3 points to 43%. Its PE isn't a useful guide right now because of how its recent earnings were reported.
VJET
Catheter Precision, Inc.
There isn't enough reported data to score VJET yet.
NVO Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| Stable | |
| Healthy |
NVO's revenue, profitability and balance sheet are currently healthy, and its cash flow is stable.
VJET Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Under pressure | |
| Weak | |
| Unavailable |
VJET's revenue is currently strong, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
NVO PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 10x | $40.65 | — |
| Cheap | 14x | $53.56 | +32% |
| Fair | 27x | $103 | +154% |
| Expensive | 39x | $152 | +273% |
Historical ranges are pointers, not guarantees.
NVO's PE is 10x, but its earnings don't support one, so it isn't a reliable read right now.
VJET PE Valuation
VJET has no meaningful PE right now: it lost money over the past year.
NVO Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Stable | |
| Growth | |
| Weakening | |
| Limited | |
| Low |
Analysts expect NVO's revenue to grow, but its profitability to weaken. However, they disagree widely on these estimates.
VJET Forward outlook
There aren't enough analyst estimates for VJET to show an outlook.
NVO Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q2 2026 | $3.89 | +4.9% |
| Q1 2026 | $4.07 | +17% |
| Q4 2025 | $3.42 | +1.8% |
| Q3 2025 | $3.47 | +10% |
| Q2 2025 | $3.71 | +24% |
| Q1 2025 | $3.49 | +18% |
| Q4 2024 | $3.36 | +21% |
| Q3 2024 | $3.15 | +27% |
NVO has the stronger earnings trend. Trailing diluted EPS is up 4.9% for NVO versus VJET down 159%.
VJET Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2023 | -$64,805.04 | +$44,178.96 |
| Q2 2023 | -$72,567.99 | +$91,782.01 |
| Q1 2023 | -$96,841.84 | +$164,408.16 |
| Q4 2022 | -$98,705.00 | +$372,495.00 |
| Q3 2020 | -$4,346,250.00 | +$7,528,750.00 |
VJET is still losing money, but far less than before: $64,805.04 per share over the past year, against $11,875,000.00 at its worst in late 2019.
NVO Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $11.7B | +2.1% |
| Q1 2026 | $14.4B | +24% |
| Q4 2025 | $11.8B | -7.6% |
| Q3 2025 | $11.1B | +5.1% |
| Q2 2025 | $11.4B | +13% |
| Q1 2025 | $11.6B | +19% |
| Q4 2024 | $12.7B | +30% |
| Q3 2024 | $10.6B | +21% |
NVO's revenue is growing: $11.7B last quarter, up 2.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 34% | -9 points |
| Q1 2026 | 62% | +12 points |
| Q4 2025 | 40% | -2.8 points |
| Q3 2025 | 32% | -16 points |
| Q2 2025 | 44% | +5.4 points |
| Q1 2025 | 50% | +1 points |
| Q4 2024 | 43% | +2.2 points |
| Q3 2024 | 47% | +1.6 points |
NVO has the edge over VJET on profitability, with a higher operating margin.
VJET Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $1M | +381% |
| Q1 2026 | $432K | +202% |
| Q4 2025 | $238K | +60% |
| Q3 2025 | $226K | +135% |
| Q2 2025 | $212K | +128% |
| Q1 2025 | $143K | +74% |
| Q4 2024 | $149K | +16% |
| Q3 2024 | $96K | -28% |
VJET has the edge over NVO on sales, with stronger typical year-over-year growth.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | -388% | +1822 points |
| Q1 2026 | -537% | +1963 points |
| Q4 2025 | -4143% | -2096 points |
| Q3 2025 | -1337% | +1641 points |
| Q2 2025 | -2210% | +711 points |
| Q1 2025 | -2500% | +690 points |
| Q4 2024 | -2048% | -19 points |
| Q3 2024 | -2978% | -926 points |
VJET's operating margin was −388% last quarter, up 1822 points from the same quarter a year ago, near the top of its range since 2019.
NVO Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $6.3B | +73% |
| Q1 2026 | $1.8B | +20% |
| Q4 2025 | -$5.4B | -$4.7B |
| Q3 2025 | $4.6B | -2.1% |
| Q2 2025 | $3.6B | -34% |
| Q1 2025 | $1.5B | +89% |
| Q4 2024 | -$632.6M | +$390.5M |
| Q3 2024 | $4.7B | +3.3% |
NVO has the edge over VJET on cash generation, producing positive trailing cash flow while its opponent burns cash.
VJET Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | -$2.9M | -$606K |
| Q1 2026 | -$2.8M | -$454K |
| Q4 2025 | -$1.5M | +$1.4M |
| Q3 2025 | -$2.2M | +$585K |
| Q2 2025 | -$2.3M | -$528K |
| Q1 2025 | -$2.3M | -$384K |
| Q4 2024 | -$2.9M | -$957K |
| Q3 2024 | -$2.8M | -$937K |
VJET has burned cash in almost every quarter: −$9M over the past year, against −$10M the year before.
NVO Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.3% | -12.9M shares |
| 1 year | -0.2% | -11M shares |
| 3 years | -1.5% | -66.8M shares |
| 5 years | -3.8% | -177M shares |
| Available history | -6.5% | -311M shares |
NVO has the edge over VJET on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $520M |
| Q1 2026 | $356.7M |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | $206.3M |
| Q4 2024 | $1.1B |
| Q3 2024 | $357.4M |
NVO spent $877M buying back its own shares over the past year, down 48% from the year before.
VJET Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +31% | +1.2K shares |
| 1 year | +41% | +1.5K shares |
| 3 years | +86633% | +5.2K shares |
VJET has 5,204 diluted shares, up 41% from a year ago.
NVO Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 0.5x | Very low |
| Q1 2026 | 0.7x | Very low |
| Q4 2025 | 0.6x | Very low |
| Q3 2025 | 0.4x | Very low |
| Q2 2025 | 0.5x | Very low |
| Q1 2025 | 0.5x | Very low |
| Q4 2024 | 0.6x | Very low |
| Q3 2024 | -0.0x | Very low |
NVO's net debt is less than a year of its operating earnings (EBITDA).
VJET Net Leverage
VJET's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
NVO Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 43.0 | Neutral |
| Stochastic | 27.0 | Neutral |
NVO's weekly RSI is 43 (neutral) and its Stochastic is 27 (neutral).
VJET Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 27.4 | Oversold |
| Stochastic | 0.7 | Oversold |
VJET's weekly RSI is 27 (oversold) and its Stochastic is 1 (oversold).
NVO PE vs Healthcare Sector
| Metric | NVO | Sector median | Relative |
|---|---|---|---|
| PE | 10x | 26x | 60% below |
| PE % | 6 | 29 | 23 pts below |
NVO is trading at 10x earnings, a 60% discount to the Healthcare sector's median of 26x, though its earnings don't support one.
VJET PE vs Healthcare Sector
VJET has no meaningful PE right now: it lost money over the past year.
NVO Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $39.2 | 3.7% above |
| 20 week MA | $43.9 | 7.4% below |
| 50 week MA | $45.3 | 10% below |
| 100 week MA | $56.3 | 28% below |
| 200 week MA | $80.7 | 50% below |
NVO has the edge over VJET on trend strength, trading above more of its moving averages.
VJET Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $0.92 | 42% below |
| 20 week MA | $2.45 | 78% below |
| 50 week MA | $9.55 | 94% below |
| 100 week MA | $29.5 | 98% below |
| 200 week MA | $689.2 | 100% below |
VJET is in a downtrend: it's below all five of its weekly moving averages, and 100% below its 200-week average.
NVO Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $29.1 | $34.7 | +19% |
| 2021 | $34.7 | $54.2 | +56% |
| 2022 | $54.2 | $67.0 | +24% |
| 2023 | $67.0 | $103.5 | +54% |
| 2024 | $103.5 | $87.4 | -16% |
| 2025 | $87.4 | $52.4 | -40% |
| 2026 YTD | $52.4 | $40.7 | -22% |
NVO has the edge over VJET on returns for 2026, with the stronger performance.
VJET Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $2,113,750.0 | $681,150.0 | -68% |
| 2021 | $681,150.0 | $164,350.0 | -76% |
| 2022 | $164,350.0 | $8,246.0 | -95% |
| 2023 | $8,246.0 | $767.6 | -91% |
| 2024 | $767.6 | $77.3 | -90% |
| 2025 | $77.3 | $16.8 | -78% |
| 2026 YTD | $16.8 | $0.53 | -97% |
VJET has finished every year since 2020 lower, and it's down 97% so far in 2026.